News

Kane Biotech Advances in Clinical Development and Finance

Kane Biotech Advances in Clinical Development and Finance

Kane Biotech Offers Important Corporate Developments

WINNIPEG, Manitoba — Kane Biotech Inc. (TSX-V:KNE) is sharing significant updates on its reorganization journey. The company emphasizes its commitment to enhancing its product distribution and financial stability.

Termination of Distribution Agreement

The Company has ended its exclusive distribution arrangement with ProgenaCare Global LLC due to multiple breaches of contract by ProgenaCare. This decision aims to allow Kane Biotech to regain control over the distribution of its products within the market.

Engagement with PrairiesCan

Recently, Kane Biotech received a notice of default from Prairies Economic Development Canada regarding a previous partnership agreement. This agreement involved a total contribution of $2,491,266, repayable over a specified period. To date, Kane Biotech has made all payments due, except for the upcoming June installment.

Prior to this notice, Kane Biotech communicated with PrairiesCan regarding a possible restructuring of the loan repayments to facilitate the completion of the payment schedule.

New Financial Approach

In a strategic move to secure its financial footing, Kane Biotech announced that it has established an unsecured demand loan of $1 million from an insider. The company plans to transition this loan into a five-year convertible debenture, pending approval from the TSX Venture Exchange. This step showcases the company’s proactive approach to financial management.

Details of the Convertible Debenture

The convertible debenture carries an interest rate of 3% per annum and is convertible into common shares of Kane Biotech at a price of $0.10 per share. This conversion is regarded as a related party transaction, so the company is exempt from specific valuation and approval requirements outlined in relevant securities regulations.

Clinical Advancements

Kane Biotech is also making strides in its clinical development. The company is executing plans to introduce its revyve™ Antimicrobial Wound Gel and revyve™ Antimicrobial Wound Gel Spray to the US market. Ongoing clinical cases with respected medical professionals target chronic wound care and burn treatment.

Expected Outcomes

These efforts are expected to yield preclinical and clinical data presentations in the upcoming years, highlighting the efficacy and potential of Kane Biotech's products in enhancing wound care.

Company Overview

Kane Biotech focuses on innovative wound care solutions aimed at disrupting biofilms, which are significant factors in antibiotic resistance and poor healing outcomes. The Company’s flagship product, revyve™, directly addresses these issues, promoting better healing results for patients.

Contact Information

If you'd like additional details or have questions, you can reach out to:

Dr. Robert Huizinga

Interim CEO
Phone: (780) 970-1100
Email: rhuizinga@kanebiotech.com

Ray Dupuis

Chief Financial Officer
Phone: (204) 298-2200
Email: rdupuis@kanebiotech.com

Frequently Asked Questions

What recent changes has Kane Biotech made in its distribution?

Kane Biotech has terminated its distribution agreement with ProgenaCare due to breaches and is working to secure new distribution channels.

How is Kane Biotech managing its financial obligations?

The company is restructuring loan repayments with PrairiesCan and has secured a new convertible debenture from an insider to support its financial strategy.

What are the key clinical trials ongoing at Kane Biotech?

Kane is conducting clinical trials for its revyve™ products focusing on chronic wound and burn care in collaboration with medical professionals in the US.

What is the significance of the convertible debenture?

The convertible debenture provides Kane Biotech with essential funding and allows for future conversion to equity, strengthening its financial position.

How does Kane Biotech address antibiotic resistance?

Kane Biotech's products target biofilms, crucial contributors to antibiotic resistance, offering innovative solutions for improved wound healing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celina Graves Joins Expanding GoLive Streamers Platform

Updated Category News Views 3

Celina Graves Breaks New Ground on GoLive Streamers You'd think television capture all the talent buzz, but nope. Celina Graves, known from her semifinalist run on America's Got Talent, is diving into new waters by joining GoLive Streamers. She's stirring up the scene by making her performances more personal, stretching beyond the flatness of your typical TV appearance....

Continue Reading
PVOLVE Expands Reach with New Franchises in 2026

Updated Category News Views 12

The PVOLVE Fitness Craze Picks Up Momentum Seriously, if you hadn’t heard of PVOLVE before, now might be the time to get your ears in tune—and maybe consider hitting up one of their studios. They’ve been on an expansion tear, with franchise deals popping up like daisies in Washington and Wisconsin. It's the two new spots in Tacoma and Brookfield that are grabbing...

Continue Reading
Schweid & Sons Reveals New Marinated Steak Tips Line

Updated Category News Views 5

No More Prep Dilemmas: Schweid & Sons Unveils Steak Tips Packing a punch in the protein aisle, Schweid & Sons throws down the gauntlet with their latest culinary innovation — Marinated Steak Tips. These aren't just your run-of-the-mill cuts, folks. We're talking premium Tri-Tip, butcher-trimmed to perfection, and marinated in both Cajun and Teriyaki styles. It's all...

Continue Reading
Colson Group Expands with Algood Acquisition

Updated Category News Views 12

A Big Move in Mobility Solutions Put on your seatbelts, because Colson Group is steering into a new lane with its acquisition of Algood Caster Innovations. This ain't just any pickup—it's a smart move that could ramp up their North American manufacturing clout and mobility solutions. You know, mergers like these don't come around by accident. Colson sees something...

Continue Reading
Schneider Electric Pushes Water Management Tech at WEFTEC

Updated Category News Views 13

Looks like Schneider Electric is diving headfirst into the choppy waters of utility management with its latest tech showcase at WEFTEC 2026. And trust me, the timing couldn't be more spot-on. With North America's water and wastewater systems groaning under the weight of aging infrastructure and cybersecurity threats, it’s about time someone brought something fresh to...

Continue Reading
Gray's Rise in ENR Rankings Highlights Sector Dominance

Updated Category News Views 6

Gray's Outstanding Reputation in the Construction Arena Nothing says “we're on top of our game” like snatching top slots in industry rankings, and that's precisely what Gray, the construction and engineering heavyweight, has managed to do. This firm recently secured impressive spots across ten different categories in the prestigious Engineering News-Record (ENR) Top...

Continue Reading
Perkins Rolls Out Mahjong to Revive Family Bonds

Updated Category News Views 8

Perkins Ditches the Phones, Sparks True Connection No doubt about it, folks—Perkins Restaurant & Bakery has cooked up something special to bring families back to the table. Not just for pancakes or pies this time, but for a little classic game action with their limited-edition Mahjong set. Love it or leave it, this is Perkins tapping into the magic of togetherness...

Continue Reading
Primrose Schools App: A Bold Step for Digital Literacy

Updated Category News Views 5

Primrose Schools Delivers a New Era in Child Education Sitting at a crossroads between the tactile charm of hands-on learning and the inevitable march of digital literacy, Primrose Schools has unveiled something that might just rock the boat in early education: their new Balanced Learning® App. This move by Primrose comes at a crucial time when many parents are...

Continue Reading
Class Action Lawsuit Hits Desert Resort Management

Updated Category News Views 4

Desert Resort Management in Labor Hot Seat Alright, here's a twist that might make your coffee spill—Desert Resort Management, Inc. is caught in a legal whirlwind in Riverside County. The heavy hitters at Blumenthal Nordrehaug Bhowmik De Blouw LLP have slapped a lawsuit right in their face, alleging some grimy labor practices. They're claiming that the company wasn't...

Continue Reading
RiskScout Rides High on Funding, Tackles Financial Crime

Updated Category News Views 4

A Fresh Injection to Combat Financial Crime Capital's flowing into RiskScout's coffers thanks to a new funding round, and it's not just about cash—it’s about gearing up for a battle against financial crime. The round was led by LiveOak Ventures, who aren't new to the block, alongside other players like Castle Creek Launchpad and Alloy Labs. After tripling their...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrate National Pesticide Safety Education Month in February

Updated Category News Views 97

National Pesticide Safety Education Month February is recognized as National Pesticide Safety Education Month, making it an ideal time to focus on enhancing awareness and understanding of pesticide safety practices. The Weed Science Society of America (WSSA), the American Phytopathological Society (APS), and the Entomological Society of America (ESA) are leading...

Continue Reading
Vistra Corp's Stock Dynamics Ahead of Earnings Report

Updated Category News Views 110

Understanding Vistra Corp's Current Stock Performance Vistra Corp (VST) is on the verge of revealing its fourth-quarter earnings, an event that has analysts and investors keenly observing. The anticipated earnings per share (EPS) is set at $1.52, while revenues are expected to reach $3.79 billion. The results will be released before market hours, making this a pivotal...

Continue Reading
Kishwaukee College Launches New Cloud-Based Student System

Updated Category News Views 117

Kishwaukee College Launches New Cloud-Based Student System AI-powered platform enhances student engagement and success at an innovative community college. Kishwaukee College has officially transitioned to using the Ellucian Colleague SaaS, a cloud-based Student Information System (SIS) and Enterprise Resource Planning (ERP) suite. This advanced platform utilizes AI...

Continue Reading
CenterPoint Energy Announces Cash Dividend for Shareholders

Updated Category News Views 195

CenterPoint Energy Declares Quarterly Dividend CenterPoint Energy, Inc., identified by the ticker symbol (NYSE: CNP), has declared a quarterly dividend of $0.2200 per share on its common stock. This decision was made during the most recent meeting of the Board of Directors, positioning the company to reward its shareholders with a consistent return on their investment....

Continue Reading
Novartis' Ianalumab Shows Promise in Sjögren's Disease Trials

Updated Category News Views 163

Novartis' New Drug Shows Efficacy in Key Trials Novartis AG (NYSE: NVS) has recently announced encouraging topline data from two pivotal Phase 3 clinical trials involving its investigational drug ianalumab (VAY736). These trials, NEPTUNUS-1 and NEPTUNUS-2, focused on adults suffering from active Sjögren’s disease, a chronic autoimmune disorder that significantly...

Continue Reading